Clinical Trials Browser

INDUSTRY × Melanoma × tocilizumab × Clear all

NCT04551352 2022-10-03

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

Phase 1 Completed

Uveal Melanoma, Melanoma